Skip to content

MENU

Contact Us

Knowledge Center

Industry Insight and Expert Knowledge to Help your Business Succeed

Staying on top of regulatory changes, new technical innovations, and industry-disrupting competitors has never been harder. With so much information available, how do you ensure you have the insight you need to drive your business forward and seize opportunities before the competition?

 

Our regulatory and scientific experts are here to help you stay up to speed with new trends and research. Let them share their expertise and insight so you can focus on building your business.

three-scientists-working

Explore our Resource Library

Browse our resource library to get more insight into the latest industry trends and a better understanding of the right regulatory framework to choose for your innovation or new product. Learn how our scientific and regulatory experts can help create competitive advantage and new business opportunities through their insight and expertise.

Filter

Brochures & Service Guides

ICH-Product-Stability-Storage-and-Analysis-Brochure
Pharmaceutical Nicotine Cannabinoids

ICH Product Stability Storage and Analysis Brochure

With over 60,000 liters of in-house ICH stability storage capacity, supported by a team of highly qualified scientists and GMP-accredited laboratory testing facilities, we have approximately 250 live studies in progress and offer a full range of stability services to help bring your product to market or ensure its ongoing compliance requirements.

 

Click to download
A-Guide-To-Pharmaceutical-Marketing-Authorization-in-the-UK
Pharmaceutical

A Guide To Pharmaceutical Marketing Authorization in the UK

The MHRA is now a stand-alone body issuing national authorizations only. This infographic outlines the routes to a Pharmaceutical Marketing Authorization in the UK.

Click to download
Pharmaceutical-Services---Extractables-and-Leachables
Pharmaceutical Nicotine Cannabinoids

Pharmaceutical Services - Extractables and Leachables

The evaluation of extractables and leachables (E&L) is an essential component of the pharmaceutical development process.

Click to download
Toxicology-Advice-and-Consultancy-Services
Pharmaceutical Nicotine Cannabinoids

Toxicology Advice and Consultancy Services

Our team of in-house toxicologists reviews and evaluates toxicological data on a wide range of chemicals to produce independent expert opinions on risk assessment. We then advise on the strategies to mitigate or reduce those risks to protect corporate reputation and public health.

Click to download
Pharma-Inhalation-Services
Pharmaceutical

Pharma Inhalation Services

Developing and commercializing new inhaled drug products, requires huge energy and deep scientific understanding. This level of resource and subject matter expertise can be difficult to maintain inside your business, and that is where we can help.

Click to download
Technical-Due-Diligence:-Product-Realization-Services
Pharmaceutical Nicotine Cannabinoids

Technical Due Diligence: Product Realization Services

Our product development and regulatory experts can help you meet expectations at key milestones in your product development project to better inform decision making and investment choices.

Click to download
Quality-Policy
Pharmaceutical Nicotine Cannabinoids

Quality Policy

We believe that the sectors we work within expect a continually improving service where we constantly strive to improve processes and Quality.

Click to download

Whitepapers

Whitepaper:-The-Use-of-Risk-Assessments-to-Optimize-your-Extractables-and-Leachables-Strategy
Pharmaceutical

Whitepaper: The Use of Risk Assessments to Optimize your Extractables and Leachables Strategy

Extractables and leachables (E&L) risk assessments are valuable processes that can identify and highlight the risks of potential leachables from both the container closure system and the manufacturing processes. The risk assessments also include the level of risk that leachables might present to user safety and product quality. Download this Whitepaper to learn more.

Click to download
Whitepaper:-Improving-the-Sustainability-of-Pressurised-Metered-Dose-Inhalers
Pharmaceutical

Whitepaper: Improving the Sustainability of Pressurised Metered Dose Inhalers

Since their introduction in 1956, pressurised metered dose inhalers (pMDIs) have become the dominant treatment choice for patients suffering from common respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD). However, unbeknown to most patients and many doctors, pMDIs account for 3.9% of NHS’s annual carbon emissions. 1Here we will discuss how formulation changes might be the answer to the pMDI-related sustainability problem.

Click to download
Whitepaper:-A-Summary-of-the-Pharmaceutical-Development-Process-Challenges-and-Opportunities-
Pharmaceutical

Whitepaper: A Summary of the Pharmaceutical Development Process Challenges and Opportunities

Broughton summarises the ‘historical’ development plan for pharmaceuticals, the changes that have occurred with regards to differential development including the requirements for biologicals, the typical challenges the industry faces now and, in the future, the opportunities this brings. This white paper forms a simplified reference point for developing pharmaceuticals both now and in the future, and some of the choices/challenges companies have

Click to download

Broughton Blog

Visit the blog
Nicotine

1 minute read

Underage Nicotine Use

Broughton CEO, Chris Allen, has written a letter to the Editor of The Grocer in response to a recent article they published about underage vaping.

Speak to an expert

Arrange a meeting with a scientific or regulatory expert to discuss your project and learn how we can help accelerate your product to market to maximize your success.



Speak to an expert